Patent directory · USPTO A61K / A61P
Patents matching “CytomX Therapeutics, Inc.”
62 pharma patents match "CytomX Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 62 pharmaceutical patents matching "CytomX Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12428470
Compositions containing activatable antibodies
granted -
US 12139543
Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR
granted -
US 12049505
Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof
granted -
US 11992528
Compositions and methods for conjugating activatable antibodies
granted -
US 11952427
Anti-CD40 antibodies and uses thereof
granted -
US 11890354
Activatable antibodies that bind epidermal growth factor receptor and methods thereof
granted -
US 11884746
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
granted -
US 11867695
Compositions and methods for detecting protease activity in biological systems
granted -
US 11859010
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
granted -
US 11814410
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
granted -
US 11802158
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same
granted -
US 11753466
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
granted -
US 11667687
Masked activatable interferon constructs
granted -
US 11548943
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
granted -
US 11548944
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
granted -
US 11472875
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
granted -
US 11472889
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
granted -
US 11306149
Anti-CD40 antibodies and uses thereof
granted -
US 11267896
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof
granted -
US 11180562
Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies
granted -
US 11174316
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
granted -
US 11168144
Activatable anti-PDL1 antibodies, and methods of use thereof
granted -
US 11161906
Multispecific antibodies, multispecific activatable antibodies and methods of using the same
granted -
US 11117968
Activatable anti-CTLA-4 antibodies and uses thereof
granted